Aripiprazole 15 MG Disintegrating Oral Tablet — RxCUI 643022
RxNorm drug concept · Semantic clinical drug
RxCUI 643022
Semantic clinical drug · SCD
● Current RxNorm concept 16 FDA products
36 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI643022
Official nameAripiprazole 15 MG Disintegrating Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped16
Package NDCs mapped36
Reported Medicaid activity (SDUD)8,610 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Aripiprazole: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Not at all — aripiprazole actually has several approved uses. It's prescribed for schizophrenia, manic or mixed episodes of Bipolar I Disorder, and as an add-on to antidepressants...
- What exactly is aripiprazole used for — is it just for schizophrenia?
- It typically takes up to two weeks for aripiprazole to build up to stable levels in your body, so don't be discouraged if you don't feel a difference right away. For some condition...
- How long does it take before I notice it working?
🕸️ Concept Web — How Aripiprazole 15 MG Disintegrating Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Aripiprazole 15 MG Disintegrating Oral Tablet
RxCUI 643022 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Aripiprazole
89013IN
-
Aripiprazole
-
Dose forms 8
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Aripiprazole Disintegrating Oral Tablet
643018SCDF -
Aripiprazole Disintegrating Oral Product
1295553SCDG -
Aripiprazole Oral Product
1158261SCDG -
Aripiprazole Pill
1158262SCDG -
Disintegrating Oral Tablet
316942DF -
Disintegrating Oral Product
1294713DFG -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Aripiprazole Disintegrating Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Aripiprazole 15 MG
350654SCDC
-
Aripiprazole 15 MG
Showing up to 8 concepts per family — 10 of 10 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Aripiprazole 15 MG
SCDC · 350654 -
Aripiprazole Disintegrating Oral Tablet
SCDF · 643018 -
Aripiprazole Disintegrating Oral Product
SCDG · 1295553 -
Aripiprazole Oral Product
SCDG · 1158261 -
Aripiprazole Pill
SCDG · 1158262
📦 FDA Products & Package NDCs
16 products · 36 package NDCs
36 package NDCs map to RxCUI 643022 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 43598-0733-30 | 30 TABLET in 1 BOTTLE (43598-733-30) | Aripiprazole | Dr. Reddy's Laboratories Inc | 2018-05-15 |
| 43598-0734-30 | 30 TABLET in 1 BOTTLE (43598-734-30) | Aripiprazole | Dr. Reddy's Laboratories Inc | 2018-05-15 |
| 46708-0260-10 | 30 TABLET, ORALLY DISINTEGRATING in 1 CARTON (46708-260-10) | Aripiprazole | Alembic Pharmaceuticals Limited | 2015-05-21 |
| 46708-0261-10 | 30 TABLET, ORALLY DISINTEGRATING in 1 CARTON (46708-261-10) | Aripiprazole | Alembic Pharmaceuticals Limited | 2015-05-21 |
| 59651-0514-03 | 3 BLISTER PACK in 1 CARTON (59651-514-03) / 10 TABLET, ORAL... | Aripiprazole | Aurobindo Pharma Limited | 2026-02-18 |
| 59651-0514-30 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (59651-514-30) | Aripiprazole | Aurobindo Pharma Limited | 2026-02-18 |
| 59651-0515-03 | 3 BLISTER PACK in 1 CARTON (59651-515-03) / 10 TABLET, ORAL... | Aripiprazole | Aurobindo Pharma Limited | 2026-02-18 |
| 59651-0515-30 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (59651-515-30) | Aripiprazole | Aurobindo Pharma Limited | 2026-02-18 |
| 62332-0103-30 | 30 TABLET, ORALLY DISINTEGRATING in 1 CARTON (62332-103-30) | Aripiprazole | Alembic Pharmaceuticals Inc. | 2016-07-07 |
| 62332-0104-30 | 30 TABLET, ORALLY DISINTEGRATING in 1 CARTON (62332-104-30) | Aripiprazole | Alembic Pharmaceuticals Inc. | 2016-07-07 |
| 69452-0338-13 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (69452... | Aripiprazole | Bionpharma Inc. | 2022-02-07 |
| 69452-0339-13 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (69452... | Aripiprazole | Bionpharma Inc. | 2022-02-07 |
| 72578-0106-06 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (72578-106-06) | Aripiprazole | Viona Pharmaceuticals Inc. | 2022-07-20 |
| 72578-0106-78 | 3 BLISTER PACK in 1 CARTON (72578-106-78) / 10 TABLET, ORAL... | Aripiprazole | Viona Pharmaceuticals Inc. | 2023-02-22 |
| 72578-0107-06 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (72578-107-06) | Aripiprazole | Viona Pharmaceuticals Inc. | 2022-07-20 |
| 72578-0107-78 | 3 BLISTER PACK in 1 CARTON (72578-107-78) / 10 TABLET, ORAL... | Aripiprazole | Viona Pharmaceuticals Inc. | 2023-02-22 |
| 76483-0100-00 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-100-00) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0100-01 | 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-100-01) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0100-02 | 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-100-02) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0100-03 | 120 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-100-03) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0100-04 | 30 TABLET, ORALLY DISINTEGRATING in 1 CARTON (76483-100-04) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2023-02-22 |
| 76483-0101-00 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-101-00) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0101-01 | 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-101-01) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0101-02 | 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-101-02) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0101-03 | 120 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-101-03) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0101-04 | 30 TABLET, ORALLY DISINTEGRATING in 1 CARTON (76483-101-04) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2023-02-22 |
| 76483-0102-00 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-102-00) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0102-01 | 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-102-01) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0102-02 | 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-102-02) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0102-03 | 120 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-102-03) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0102-04 | 30 TABLET, ORALLY DISINTEGRATING in 1 CARTON (76483-102-04) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2023-02-22 |
| 76483-0103-00 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-103-00) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0103-01 | 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-103-01) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0103-02 | 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-103-02) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0103-03 | 120 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (76483-103-03) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2022-07-20 |
| 76483-0103-04 | 30 TABLET, ORALLY DISINTEGRATING in 1 CARTON (76483-103-04) | Aripiprazole | SQUARE PHARMACEUTICALS LIMITED | 2023-02-22 |
Observed labelers:
SQUARE PHARMACEUTICALS LIMITED (20) ·
Aurobindo Pharma Limited (4) ·
Viona Pharmaceuticals Inc. (4) ·
Alembic Pharmaceuticals Inc. (2) ·
Alembic Pharmaceuticals Limited (2) ·
Bionpharma Inc. (2)
· +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.